Handling the Holidays with Cancer

A KidneyCAN Town Hall Event

The holidays can be a stressful and hectic time of year. Coping with cancer at the same time can be overwhelming. We have a panel of experienced patients and caregivers, along with medical professionals, to share strategies to support your overall wellbeing during the holiday season.

We are getting started shortly! Click to enter the Zoom webinar. 

Experienced  Patients, Caregivers, and Medical Professionals Offer Their Best Holiday Strategies

Join us for an interactive meeting with panelists who understand the challenges of kidney cancer, moderated by Frank Eady, a genitourinary social worker from Emory Winship Cancer Center. Our session will consist of three topics:

“But We Always …” : Managing Holiday Expectations and Energy

Feeling Your Best (Even When It’s Not That Great)

Banish the Bah Humbugs: Keeping Up Your Holiday Spirits

Panelists include experienced patients and caregivers, along with a medical oncologist, a dietician, and a nurse living with kidney cancer.

The first hour will allow attendees to ask questions as they listen to the panelists. Following the formal session, we’ll conclude with an “eggnog happy hour” breakout session for attendees to chat and interact directly.

Register Now

Tuesday, November 30th

5:30-6:30 pm ET, with an “eggnog happy hour” to follow

Zoom Webinar

Webinar link will be sent via email.

"*" indicates required fields

Name*
I am a:*

What questions do you have about managing holiday expectations and your energy level?
What questions do you have about feeling your best physically?
What questions do you have about feeling your best emotionally and mentally (keeping up your spirits)?
This field is for validation purposes and should be left unchanged.

You’re not alone this holiday season.

Veteran patients and caregivers, along with a medical oncologist, a dietician, and a registered nurse living with kidney cancer will share their very best tips for enjoying the holiday season as you deal with cancer. Mark your calendars and join the conversation!

This event supported by

Click here for patient resources from AVEO Oncology.

For Patients

Advocacy

Research

Join Our Grassroots Army

We know that awareness of kidney cancer and its impact on many lives leads to a sense of urgency, a desire for solutions. Awareness leads to advocacy, and advocacy — joining to speak as one voice — leads to funding and research. That’s how we get to cures.

Join this free symposium to understand how your quality of life and symptom management during #kidneycancer treatment can be improved by support from palliative care specialists. 
This event is provided by our friends at the Judy Nicholson Kidney Cancer Foundation. Register here: https://jnfkidneycancer.org/supporting-patients-family-the-role-of-palliative-care/

Join this free symposium to understand how your quality of life and symptom management during #kidneycancer treatment can be improved by support from palliative care specialists.

This event is provided by our friends at the Judy Nicholson Kidney Cancer Foundation. Register here: https://jnfkidneycancer.org/supporting-patients-family-the-role-of-palliative-care/
...

5 0
Does #kidneycancer run in my family? 
What do my genes tell me about kidney cancer?
On October 1st, Dr. Nathanson will break down risks of kidney cancer that runs in families in language we can all understand. She will present the very latest research in the field of kidney cancer genetics, offering information to share with family members and inform decision-making.
More information and registration at: https://www.med.upenn.edu/kidney2021/

Does #kidneycancer run in my family?

What do my genes tell me about kidney cancer?

On October 1st, Dr. Nathanson will break down risks of kidney cancer that runs in families in language we can all understand. She will present the very latest research in the field of kidney cancer genetics, offering information to share with family members and inform decision-making.

More information and registration at: https://www.med.upenn.edu/kidney2021/
...

8 1
Today’s science may lead to breakthrough treatments for a life-threatening condition that affects millions. To deliver on that promise, we need sustained, robust funding for the National Institutes of Health.
Today, KidneyCAN joins Rally for Medical Research to ask #Congress to fund the NIH. 
Here's why:
• Medical research funded through the NIH, the largest source of funding for medical research in the world, has been a driving force behind many decades of advances that have improved the health of people in every corner of America. 
• Thanks in large part to NIH-funded research, Americans are living longer, healthier lives and advances that were once unimaginable, such as sequencing the human genome, have been achieved and have opened a world of unprecedented opportunities for science, medicine and health. 
• NIH funding contributed to every one of the 210 new drugs approved by the Food and Drug Administration (FDA) between 2010 and 2016, including 84 first-in-class products to treat a wide range of diseases. 
• Investment in medical research can limit future costs of care. The vast majority of our health care dollars are spent on treating chronic diseases that could be managed more effectively with better therapies or, in some cases, prevented. We can meet these challenges head-on, but in order to do so, medical research must be a strong national priority.
#RallyMedRes #FundNIH

Today’s science may lead to breakthrough treatments for a life-threatening condition that affects millions. To deliver on that promise, we need sustained, robust funding for the National Institutes of Health.

Today, KidneyCAN joins Rally for Medical Research to ask #Congress to fund the NIH.

Here's why:

• Medical research funded through the NIH, the largest source of funding for medical research in the world, has been a driving force behind many decades of advances that have improved the health of people in every corner of America.

• Thanks in large part to NIH-funded research, Americans are living longer, healthier lives and advances that were once unimaginable, such as sequencing the human genome, have been achieved and have opened a world of unprecedented opportunities for science, medicine and health.

• NIH funding contributed to every one of the 210 new drugs approved by the Food and Drug Administration (FDA) between 2010 and 2016, including 84 first-in-class products to treat a wide range of diseases.

• Investment in medical research can limit future costs of care. The vast majority of our health care dollars are spent on treating chronic diseases that could be managed more effectively with better therapies or, in some cases, prevented. We can meet these challenges head-on, but in order to do so, medical research must be a strong national priority.

#RallyMedRes #FundNIH
...

17 1
Did you know? September 21 is #TakeALovedOneToTheDoctor day! 
Building a care team and getting support is a key piece of your cancer journey. Check out KidneyCAN's resources for patients and caregivers at https://kidneycan.org/build-a-care-team/

Did you know? September 21 is #TakeALovedOneToTheDoctor day!

Building a care team and getting support is a key piece of your cancer journey. Check out KidneyCAN's resources for patients and caregivers at https://kidneycan.org/build-a-care-team/
...

5 0
We just published our August newsletter, filled with exciting #kidneycancer research updates, news, and events. Don't miss a very special feature highlighting an inspiring member of our community. 
Have a great weekend! 
https://conta.cc/3sRMguh

We just published our August newsletter, filled with exciting #kidneycancer research updates, news, and events. Don't miss a very special feature highlighting an inspiring member of our community.

Have a great weekend!

https://conta.cc/3sRMguh
...

7 2
REMINDER: Do you have questions about participating in clinical trials and how to find trials for you? Do you know the risks and benefits? We are hosting a special Facebook Live with a medical oncologist and clinical trial patient to answer all your questions live, including:
• What is a clinical trial?
• Where do I find clinical trials for kidney cancer?
• What are important questions to ask about a trial?
• What is informed consent?
• What are good clinical practices?
• What can patients expect during a trial?
• What are the risks and benefits of participating in a trial?
• What is the difference between participating at an academic institution versus a freestanding clinical research organization (CRO)?
Will you join us? RSVP now so you get a Facebook notification when we go live: https://fb.me/e/1JfopJa6J

REMINDER: Do you have questions about participating in clinical trials and how to find trials for you? Do you know the risks and benefits? We are hosting a special Facebook Live with a medical oncologist and clinical trial patient to answer all your questions live, including:

• What is a clinical trial?
• Where do I find clinical trials for kidney cancer?
• What are important questions to ask about a trial?
• What is informed consent?
• What are good clinical practices?
• What can patients expect during a trial?
• What are the risks and benefits of participating in a trial?
• What is the difference between participating at an academic institution versus a freestanding clinical research organization (CRO)?

Will you join us? RSVP now so you get a Facebook notification when we go live: https://fb.me/e/1JfopJa6J
...

5 0
🚨🚨 RESEARCH NEWS
Lenvantinib (by Eisai) + Keytruda (by Merck) is now 
U.S. Food and Drug Administration approved for #kidneycancer. Wonderful to have this powerful new combo as a treatment option for patients with advanced #RCC!
Dr. Toni Choueiri of Dana-Farber Cancer Institute says, "This is another important combination option for advanced kidney cancer patients. The results in term of responses including complete responders are the highest to date, albeit with a bit different patient populations. The hope is to continue building on doublets, like pembro/Len with other active drugs, that are able to induce more deep and sustainable remissions."
Great news! 
More information here: https://cancernetwork.com/view/pembrolizumab-lenvatinib-approved-by-the-fda-for-the-treatment-of-first-line-advanced-rcc

🚨🚨 RESEARCH NEWS
Lenvantinib (by Eisai) + Keytruda (by Merck) is now
U.S. Food and Drug Administration approved for #kidneycancer. Wonderful to have this powerful new combo as a treatment option for patients with advanced #RCC!

Dr. Toni Choueiri of Dana-Farber Cancer Institute says, "This is another important combination option for advanced kidney cancer patients. The results in term of responses including complete responders are the highest to date, albeit with a bit different patient populations. The hope is to continue building on doublets, like pembro/Len with other active drugs, that are able to induce more deep and sustainable remissions."

Great news!

More information here: https://cancernetwork.com/view/pembrolizumab-lenvatinib-approved-by-the-fda-for-the-treatment-of-first-line-advanced-rcc
...

6 0
We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.
For #DistrictDays, the #kidneycancer community is meeting with members of #Congress all over the United States to ask for robust funding of kidney cancer research. 
We want Congress to 
1. Maintain the $50 million currently allocated for KCRP for
Fiscal Year 2022. 
2. Increase the NIH budget by $3.5 billion for Fiscal Year 2022. 
3. Support the creation of ARPA-H (the Advanced Research
Projects Agency - Health) at NIH with an additional $3 billion.
4. Continue supporting legislative initiatives that contribute to
robust, sustainable funding for medical research.
5. Continue to incorporate the patient perspective on legislative policy matters.
Thank you to the many delegates from all over the country who are speaking on behalf of patients, caregivers, friends, and family members today. Thank you to doctors and researchers from the medical community who've made time today to lift their voices with ours. 
Let's work together to #fundthecure.
#AcceleratingCures

We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.

For #DistrictDays, the #kidneycancer community is meeting with members of #Congress all over the United States to ask for robust funding of kidney cancer research.

We want Congress to

1. Maintain the $50 million currently allocated for KCRP for
Fiscal Year 2022.
2. Increase the NIH budget by $3.5 billion for Fiscal Year 2022.
3. Support the creation of ARPA-H (the Advanced Research
Projects Agency - Health) at NIH with an additional $3 billion.
4. Continue supporting legislative initiatives that contribute to
robust, sustainable funding for medical research.
5. Continue to incorporate the patient perspective on legislative policy matters.

Thank you to the many delegates from all over the country who are speaking on behalf of patients, caregivers, friends, and family members today. Thank you to doctors and researchers from the medical community who've made time today to lift their voices with ours.

Let's work together to #fundthecure.

#AcceleratingCures
...

13 0
Thank you to Senator Grassley's office for meeting with us today. Here, KidneyCAN President and #kidneycancer survivor Bryan Lewis, along with our friend and patient Shari, and Dr. Zakharia speak up about the need for robust research funding. 
76,000+ will be diagnosed in 2021. 
14,000 Americans will lose their lives to kidney cancer this year. 
It's urgent! Let's #fundthecure.
#acceleratingcures #districtdays

Thank you to Senator Grassley's office for meeting with us today. Here, KidneyCAN President and #kidneycancer survivor Bryan Lewis, along with our friend and patient Shari, and Dr. Zakharia speak up about the need for robust research funding.

76,000+ will be diagnosed in 2021.
14,000 Americans will lose their lives to kidney cancer this year.

It's urgent! Let's #fundthecure.

#acceleratingcures #districtdays
...

20 2
Here we go! 
#KidneyCancer advocates across the #USA are speaking with #onevoice today. We're asking #Congress to #fundthecure with robust research funding for the National Institutes of Health, the Congressionally Directed Medical Research Programs - Kidney Cancer Research Program, and ARPA-H, which will devote specific funding to cancer research initiatives.
We lose 40 people per day to kidney cancer. This is urgent. The time is NOW.

Here we go!

#KidneyCancer advocates across the #USA are speaking with #onevoice today. We're asking #Congress to #fundthecure with robust research funding for the National Institutes of Health, the Congressionally Directed Medical Research Programs - Kidney Cancer Research Program, and ARPA-H, which will devote specific funding to cancer research initiatives.

We lose 40 people per day to kidney cancer. This is urgent. The time is NOW.
...

12 2

KidneyCAN is a registered 501(c)(3) nonprofit and does not receive any funding through the Congressionally Directed Medical Research Programs (CDMRP) or KCRP (Kidney Cancer Research Program). Our work is funded by grassroots donors in the kidney cancer community. 

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORY BOARD →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Meet the Lesicas: Moving Forward

Meet the Lesicas: Moving Forward

Tony Lesica, age 58, lives in Connecticut with his wife Jennine. A semi-retired financial planner, Tony is a chess player and football fan. He has three children: Jacquelyn (pictured here), Johnny, and Stacy. Tony was diagnosed with kidney cancer when he was 51 years old.Pillars of Support,...

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

District Days 2021: Speaking with One Voice

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for robust funding of kidney cancer...

FACING KIDNEY CANCER →

DIAGNOSIS →

BUILDING A CARE TEAM →

LEARN ABOUT CLINICAL TRIALS →

LIVING WELL WITH KIDNEY CANCER →

HANDLING THE HOLIDAYS WITH CANCER →

DONATE →

CONTACT →

Latest News

Handling the Holidays with Cancer: A KidneyCAN Town Hall Event

Handling the Holidays with Cancer: A KidneyCAN Town Hall Event

Don't miss the latest KidneyCAN Town Hall! These events are interactive virtual webinars for patients and caregivers to get information and resources for living with kidney cancer. On November 30th, KidneyCAN will host "Holidays with Cancer: Creating a New Normal for the Holiday Season." Read all...

KCRS →

RESEARCH OPPORTUNITIES →

ADVOCATE WITH KIDNEYCAN →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

District Days 2021: Speaking with One Voice

District Days 2021: Speaking with One Voice

Our Ask: Fund Kidney Cancer Research We lose almost 40 people per day to kidney cancer in the United States. The need for research funding is urgent.For District Days, the kidney cancer community met with members of Congress all over the United States to ask for robust funding of kidney cancer...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

Handling the Holidays with Cancer: A KidneyCAN Town Hall Event

Handling the Holidays with Cancer: A KidneyCAN Town Hall Event

Don't miss the latest KidneyCAN Town Hall! These events are interactive virtual webinars for patients and caregivers to get information and resources for living with kidney cancer. On November 30th, KidneyCAN will host "Holidays with Cancer: Creating a New Normal for the Holiday Season." Read all...